Opendata, web and dolomites


Chemical probing of transcriptional RAS effectors

Total Cost €


EC-Contrib. €






 ChemRAS project word cloud

Explore the words cloud of the ChemRAS project. It provides you a very rough idea of what is the project "ChemRAS" about.

facile    mutant    microscopy    protein    fail    therapeutic    center    amenable    academy    background    modulation    underpinning    deadly    dependent    genetic    regulation    active    disruption    pancreatic    transduction    treatment    translated    disease    models    devise    tumors    understand    remodeling    drug    screens    phenotypic    acute    regulatory    mechanism    computational    pipelines    targeted    signaling    cellular    austrian    coupled    clinical    block    interface    confluence    elicited    nodes    ras    chemical    usually    clinic    urgent    resistances    hence    cancers    throughput    interfere    molecular    readout    reporters    sciences    action    gene    attractive    exemplified    cemm    oncogenic    experimental    molecules    avenues    dependencies    chromatin    oncogenes    engineering    pharmacologic    medicine    transcriptional    prone    unfortunately    hyperactive    building    cancer    aggressive    point    critical    kras    resistance    inhibitors    multiple    regulators    transcription    laboratory    imposed    networks    degradation    attempts    therapies    signal    winter    perturbations    transcriptionally    emergence    innovative    me   

Project "ChemRAS" data sheet

The following table provides information about the project.


Organization address
address: LAZARETTGASSE 14 AKH BT 25.3
city: WIEN
postcode: 1090

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 178˙156 €
 EC max contribution 178˙156 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-02-15   to  2021-02-14


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Targeted therapies have been widely used in tumors driven by RAS oncogenes. Unfortunately, no effective RAS inhibitors have been translated to the clinic, and attempts to block other signaling nodes usually fail due to the emergence of drug resistance. Chromatin dependent signal transduction and transcription are a point of confluence of multiple signaling networks elicited by hyperactive RAS. Hence, pharmacologic disruption of gene-regulatory dependencies imposed by mutant RAS represents an attractive therapeutic interface less prone to the emergence of resistances. The urgent clinical need of RAS-related therapies is well exemplified by pancreatic cancer, one of the most aggressive and deadly cancers, which will be the disease background of my studies. Using the innovative approach of targeted protein degradation, I want to characterize and understand the consequences of acute mutant KRAS degradation on chromatin remodeling and transcription. Further engineering the models of acute KRAS degradation will enable to devise cellular reporters of KRAS-dependent chromatin regulation amenable to high-throughput phenotypic drug and genetic screens. Coupled to a facile readout via high-throughput microscopy, these screens will allow me to identify molecules and genetic perturbations that interfere with KRAS-dependent, transcriptionally active chromatin. Lead molecules will be characterized for the underpinning mechanism of action and assessed for therapeutic potential. Building on already existing experimental and computational pipelines in the Winter laboratory at CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, this project will increase the understanding of transcriptional control elicited by oncogenic KRAS and could open new avenues for the treatment of RAS-driven tumors based on chemical modulation of critical chromatin and transcription regulators.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CHEMRAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CHEMRAS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LearningEmotions (2020)

Emotion Recognition: A Statistical Learning Approach

Read More  

GENESE 17 (2018)

Geometries of Exotic NuclEar StructurE 17

Read More  

Drought (2020)

Drought coping strategies in southern Africa 1966-2016

Read More